Swiss Life Asset Management Ltd Purchases 11,044 Shares of The Clorox Company $CLX

13 May 2026, 06:04 by Jessica Moore · The Cerbat Gem

Swiss Life Asset Management Ltd raised its position in shares of The Clorox Company (NYSE:CLX – Free Report) by 12.8% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 97,470 shares of the company’s stock after purchasing an additional 11,044 shares during the quarter. Swiss Life Asset Management Ltd owned 0.08% of Clorox worth $9,828,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also bought and sold shares of the company. State Street Corp increased its stake in Clorox by 3.5% during the 3rd quarter. State Street Corp now owns 8,434,277 shares of the company’s stock valued at $1,039,946,000 after purchasing an additional 282,794 shares in the last quarter. Invesco Ltd. increased its stake in Clorox by 23.1% during the 3rd quarter. Invesco Ltd. now owns 3,995,590 shares of the company’s stock valued at $492,656,000 after purchasing an additional 750,415 shares in the last quarter. Van ECK Associates Corp increased its stake in Clorox by 93.9% during the 3rd quarter. Van ECK Associates Corp now owns 2,709,972 shares of the company’s stock valued at $334,139,000 after purchasing an additional 1,312,471 shares in the last quarter. Two Sigma Investments LP increased its stake in Clorox by 33.8% during the 3rd quarter. Two Sigma Investments LP now owns 1,740,175 shares of the company’s stock valued at $214,564,000 after purchasing an additional 439,797 shares in the last quarter. Finally, Northern Trust Corp increased its stake in Clorox by 4.8% during the 3rd quarter. Northern Trust Corp now owns 1,539,006 shares of the company’s stock valued at $189,759,000 after purchasing an additional 70,783 shares in the last quarter. 78.53% of the stock is currently owned by institutional investors.

Clorox Stock Performance

Shares of CLX stock opened at $89.08 on Wednesday. The company has a 50 day moving average price of $103.83 and a 200-day moving average price of $107.43. The Clorox Company has a 52 week low of $84.70 and a 52 week high of $138.03. The firm has a market capitalization of $10.77 billion, a PE ratio of 14.46, a P/E/G ratio of 0.46 and a beta of 0.59. The company has a quick ratio of 0.65, a current ratio of 0.84 and a debt-to-equity ratio of 27.03.

Clorox (NYSE:CLX – Get Free Report) last announced its quarterly earnings results on Thursday, April 30th. The company reported $1.64 EPS for the quarter, topping analysts’ consensus estimates of $1.55 by $0.09. Clorox had a net margin of 11.18% and a return on equity of 443.64%. The firm had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.67 billion. During the same period in the previous year, the business posted $1.45 earnings per share. The business’s revenue for the quarter was up .1% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. As a group, equities research analysts expect that The Clorox Company will post 5.63 earnings per share for the current year.

Clorox Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, May 8th. Investors of record on Wednesday, April 22nd were given a dividend of $1.24 per share. This represents a $4.96 annualized dividend and a yield of 5.6%. The ex-dividend date was Wednesday, April 22nd. Clorox’s payout ratio is 80.52%.

Wall Street Analyst Weigh In

A number of analysts have weighed in on the stock. Rothschild & Co Redburn set a $117.00 price objective on shares of Clorox in a research note on Friday, February 13th. Jefferies Financial Group reduced their price objective on shares of Clorox from $139.00 to $125.00 and set a “buy” rating for the company in a research note on Monday, May 4th. Royal Bank Of Canada reduced their price objective on shares of Clorox from $132.00 to $127.00 and set a “sector perform” rating for the company in a research note on Thursday, April 9th. Wells Fargo & Company reduced their price target on shares of Clorox from $110.00 to $100.00 and set an “equal weight” rating for the company in a research note on Friday, May 1st. Finally, Citigroup reduced their price target on shares of Clorox from $110.00 to $97.00 and set a “neutral” rating for the company in a research note on Friday, May 1st. One equities research analyst has rated the stock with a Buy rating, twelve have given a Hold rating and four have issued a Sell rating to the stock. According to data from MarketBeat.com, Clorox currently has a consensus rating of “Reduce” and a consensus price target of $103.73.

Read Our Latest Analysis on CLX

Insider Transactions at Clorox

In other Clorox news, Director Pierre R. Breber bought 5,000 shares of the business’s stock in a transaction that occurred on Tuesday, May 5th. The stock was bought at an average cost of $85.82 per share, for a total transaction of $429,100.00. Following the completion of the transaction, the director owned 18,000 shares of the company’s stock, valued at $1,544,760. This represents a 38.46% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 0.63% of the company’s stock.

About Clorox

(Free Report)

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.